Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor Efficacy and Endothelial Nitric Oxide (PLATE NOX)
NCT02169596Phase 4Completed
- Sponsor
- Hull University Teaching Hospitals
- Start
- Jun 2015
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in acute coronary syndrome (ACS), sponsored by Hull University Teaching Hospitals. Started Jun 2015; status: completed.
02
Drugs
ticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02169596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02169596.